Skip to content
★ Sign in to follow
DW

D Waterhouse

GlaxoSmithKline plc
Total declarations
46
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€326k

Latest filing published 13 May 2021 for GlaxoSmithKline plc, €281.

Filing timeline

BuySale
D Waterhouse

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

D Waterhouse: trading record in brief

All filings by D Waterhouse on record concern GlaxoSmithKline plc. In total, 46 filings cover trades dated from 9 January 2020 to 12 May 2021.

Every open-market trade on record is a sale: 1 sale worth €326k. The rest of the record consists of 45 share grants.

Most recently, on 13 May 2021, the filings show a share grant worth €281 in GlaxoSmithKline plc. Typically, a trade is published a median of 2 days after it takes place. For comparison, UK MAR gives managers three business days to notify a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to D Waterhouse

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations46 total
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    241 GBP0FCA-NSM
    18 shares@ £13.4072London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3974287-10
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    3,383 GBP0FCA-NSM
    261.189 shares@ £12.9508London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3944285-12
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    258 GBP0FCA-NSM
    20 shares@ £12.906London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3943193-10
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    2,696 GBP0FCA-NSM
    204 shares@ £13.216London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3943052-15
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    1,287 GBP0FCA-NSM
    98 shares@ £13.1367London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3938809-11
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    228 GBP0FCA-NSM
    18 shares@ £12.6711London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3908301-10
  • ◆
    CEO of ViiV HealthcareExecutivesGlaxoSmithKline plc
    0FCA-NSM
    15,302.697 sharesN/AISIN GB0009252882FCA-NSM:3885989-1
  • ◆
    CEO of ViiV HealthcareExecutivesGlaxoSmithKline plc
    0FCA-NSM
    15,160 sharesN/AISIN GB0009252882FCA-NSM:3885696-6
  • ◆
    CEO of ViiV HealthcareExecutivesGlaxoSmithKline plc
    90,371 GBP0FCA-NSM
    7,126 shares@ £12.6818London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3885696-7
  • ◆
    CEO of ViiV HealthcareExecutivesGlaxoSmithKline plc
    0FCA-NSM
    5,917 sharesLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3882407-13
  • ◆
    CEO, ViiV HealthcareExecutivesGlaxoSmithKline plc
    0FCA-NSM
    12,589 sharesN/AISIN GB0009252882FCA-NSM:3879317-14
  • ◆
    CEO of ViiV HealthcareExecutivesGlaxoSmithKline plc
    1M GBP0FCA-NSM
    78,431.373 shares@ £12.75n/aISIN GB0009252882FCA-NSM:3878377-3
  • ◆
    CEO of ViiV HealthcareExecutivesGlaxoSmithKline plc
    0FCA-NSM
    11,727 sharesN/AISIN GB0009252882FCA-NSM:3878373-14
  • ◆
    CEO of ViiV HealthcareExecutivesGlaxoSmithKline plc
    0FCA-NSM
    117,462 sharesN/AISIN GB0009252882FCA-NSM:3878367-15
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    254 GBP0FCA-NSM
    20 shares@ £12.717London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3875131-10
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    0 GBP0FCA-NSM
    0.014 shares@ £14.2857London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3850615-12
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    1,054 GBP0FCA-NSM
    76 shares@ £13.8718London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3847444-11
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    249 GBP0FCA-NSM
    18 shares@ £13.8428London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3844188-10
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    252 GBP30FCA-NSM
    18 shares@ £14.0272100.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3811317-10
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    263 GBP0FCA-NSM
    18 shares@ £14.6233London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3777599-10
  • ▼
    CEO of ViiV HealthcareExecutivesGlaxoSmithKline plc
    293,827 GBP0FCA-NSM
    21,828 shares@ £13.461London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3770272
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    4,094 GBP0FCA-NSM
    284.256 shares@ £14.4008London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746934-14
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    230 GBP0FCA-NSM
    16 shares@ £14.3994London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746905-10
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    1,012 GBP0FCA-NSM
    71 shares@ £14.2576London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746881-10
  • ◆
    Chief Executive Officer of ViiV HealthcareExecutivesGlaxoSmithKline plc
    274 GBP0FCA-NSM
    18 shares@ £15.2033London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3714306-10

25 of 46 declarations